IFP Advisors Inc lifted its stake in PetMed Express, Inc. (NASDAQ:PETS) by 269.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,742 shares of the company’s stock after purchasing an additional 10,754 shares during the quarter. IFP Advisors Inc owned about 0.07% of PetMed Express worth $489,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in the stock. Pinebridge Investments L.P. increased its holdings in PetMed Express by 1.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after buying an additional 27 shares during the period. Texas Permanent School Fund increased its holdings in PetMed Express by 0.8% in the 2nd quarter. Texas Permanent School Fund now owns 14,986 shares of the company’s stock worth $608,000 after buying an additional 125 shares during the period. Advisor Group Inc. increased its holdings in PetMed Express by 0.7% in the 2nd quarter. Advisor Group Inc. now owns 24,844 shares of the company’s stock worth $1,009,000 after buying an additional 179 shares during the period. QS Investors LLC increased its holdings in PetMed Express by 4.0% in the 2nd quarter. QS Investors LLC now owns 9,324 shares of the company’s stock worth $379,000 after buying an additional 356 shares during the period. Finally, Thrivent Financial For Lutherans increased its holdings in PetMed Express by 4.1% in the 1st quarter. Thrivent Financial For Lutherans now owns 11,530 shares of the company’s stock worth $232,000 after buying an additional 450 shares during the period. 87.13% of the stock is owned by hedge funds and other institutional investors.
PetMed Express, Inc. (PETS) opened at $37.39 on Wednesday. PetMed Express, Inc. has a 52-week low of $19.21 and a 52-week high of $50.90. The stock has a market capitalization of $770.40, a P/E ratio of 25.09, a PEG ratio of 2.26 and a beta of 1.09.
PetMed Express (NASDAQ:PETS) last announced its earnings results on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The firm had revenue of $66.70 million for the quarter, compared to analyst estimates of $63.41 million. During the same quarter last year, the firm posted $0.24 EPS. The business’s revenue was up 9.7% on a year-over-year basis. analysts expect that PetMed Express, Inc. will post 1.66 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 17th. Stockholders of record on Monday, November 6th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 3rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.14%. PetMed Express’s dividend payout ratio (DPR) is 53.69%.
In other news, Director Ronald J. Korn sold 1,000 shares of the stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $35.57, for a total transaction of $35,570.00. Following the transaction, the director now owns 73,833 shares in the company, valued at approximately $2,626,239.81. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 4.00% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://weekherald.com/2017/11/15/ifp-advisors-inc-grows-position-in-petmed-express-inc-pets.html.
Several equities analysts recently weighed in on PETS shares. Sidoti upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price target on the stock in a report on Thursday, August 24th. BidaskClub downgraded shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a report on Tuesday, August 22nd. Zacks Investment Research upgraded shares of PetMed Express from a “sell” rating to a “hold” rating and set a $50.00 price target on the stock in a report on Friday, October 20th. Northcoast Research raised shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price objective on the stock in a research note on Monday, July 24th. Finally, Noble Financial reaffirmed a “hold” rating on shares of PetMed Express in a research note on Friday, October 27th. One research analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $42.00.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.